AdvanSix (ASIX) Reports Q3 Earnings: What Key Metrics Have to Say

Core Insights - AdvanSix reported a revenue of $398.19 million for the quarter ended September 2024, reflecting a year-over-year increase of 23.3% and surpassing the Zacks Consensus Estimate by 11.33% [1] - The company's EPS for the quarter was $0.88, a significant improvement from -$0.36 in the same quarter last year, resulting in an EPS surprise of 33.33% over the consensus estimate of $0.66 [1] Revenue Breakdown - Sales from Nylon amounted to $93.69 million, slightly below the average estimate of $97.51 million, marking an 8.9% increase year-over-year [3] - Sales of Ammonium Sulfate reached $107.67 million, exceeding the estimated $87.15 million, representing a 27.3% increase compared to the previous year [3] - Chemical Intermediates sales were reported at $120.49 million, significantly above the estimated $103.75 million, with a year-over-year growth of 44.4% [3] - Caprolactam sales totaled $76.34 million, which was below the average estimate of $79 million, but still showed an 11% increase year-over-year [3] Stock Performance - Over the past month, AdvanSix shares have returned -9%, compared to a -1% change in the Zacks S&P 500 composite [4] - The stock currently holds a Zacks Rank 2 (Buy), suggesting potential for outperformance against the broader market in the near term [4]